[1] [1] BENJAMIN EJ, WOLF PA, D'AGOSTINO RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study [J]. Circulation, 1998, 98(10): 946-952.

[3] [3] WILBER DJ, PAPPONE C, NEUZIL P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial[J]. JAMA, 2010, 303(4): 333-340.

[4] [4] NATALE A, REDDY VY, MONIR G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial[J]. J Am Coll Cardiol, 2014, 64(7): 647-656.

[5] [5] REDDY VY, DUKKIPATI SR, NEUZIL P, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study [J]. Circulation, 2015, 132(10): 907-915.

[6] [6] POPA MA, BOURIER F, LENGAUER S, et al. Safety profile and long-term efficacy of very high-power short-duration (60-70W) catheter ablation for atrial fibrillation: results of a large comparative analysis [J]. Europace, 2023, 25(2): 408-416.

[7] [7] ZHANG R, CHU H, LIU S, et al. Catheter ablation of atrial fibrillation using FireMagic TrueForce ablation catheter: the TRUEFORCE trial [J]. Pacing Clin Electrophysiol, 2023, 46(8): 986-993.

[8] [8] Sorgente A, Cappato R. Complications of catheter ablation: incidence, diagnosis and clinical management [J]. Herzschrittmacherther Elektrophysiol, 2019, 30(4): 363-370.